APP and Alzheimer disease: It has been shown that the abnormal processing of APP by β and γ-secretase protease enzymes is a key event in the development of AD neuropathology [88], resulting in an increase in the generation of the Aβ42 which aggregates to form the insoluble amyloid plaques.